A Study of CAR-T Cells Targeting Autoimmune Diseases

Sponsor
Beijing Boren Hospital
Study ID
NCT06661811
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Autoimmune Diseases

Eligibility Criteria

Sex
ALL
Age
18 Years - 65 Years
Healthy Volunteers
Not accepted

Interventions

  • CAR-T — DRUG
    CAR-T cells

Study Details

The purpose of this study is to assess the safety and efficacy of CAR-T cell therapy in patients with autoimmune disease.

Key Dates

First listed
Oct 28, 2024
Start date
Nov 15, 2024
Status verified
Oct 2024
Primary completion
Apr 20, 2028
Completion
Jun 20, 2028

Study Design

Enrollment
12 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: CAR-T treatment

Primary Outcome Measure

Dose Limiting Toxicity [ Time Frame: 0~28 day after treatment ]

Central Contacts

Related Studies